REGENERON PHARMACEUTICALS, INC. Annual Nonoperating Income (Expense) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Regeneron Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
  • Regeneron Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $559M, a 741% increase year-over-year.
  • Regeneron Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $682M, a 54.5% increase year-over-year.
  • Regeneron Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $152M, a 26.9% increase from 2022.
  • Regeneron Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $120M, a 68.4% decline from 2021.
  • Regeneron Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $379M, a 62.1% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $152M +$32.3M +26.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-05
2022 $120M -$259M -68.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-05
2021 $379M +$145M +62.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-05
2020 $234M +$14.5M +6.61% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-06
2019 $219M +$200M +1048% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-07
2018 $19.1M +$20.2M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-08
2017 -$1.1M -$200K -22.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-07
2016 -$900K +$25.9M +96.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-07
2015 -$26.8M +$35.9M +57.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-08
2014 -$62.7M -$16M -34.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-09
2013 -$46.7M -$3.38M -7.8% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-11
2012 -$43.3M -$25.6M -144% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-12
2011 -$17.7M -$10.7M -153% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-13
2010 -$7M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.